FDA
Entity.
- Evidence
- 1,979 documents · 186 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 Apr 2026, last seen 10 Oct 2026
- Measured
- 50% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- FDA Drug News · 2026-10-10 · [APPROVAL] FDA Approves Drug to Treat Lesions Caused by Herpes Simplex Virus (opens the source in a new tab)
- The Hindu · 2026-10-10 · Maharashtra to soon introduce digital system for milk tracking to curb adulteration: FDA chief (opens the source in a new tab)
- Fierce Pharma · 2026-10-09 · Teva debuts Weltruza in schizophrenia as much-hyped FDA nod for long-acting olanzapine arrives (opens the source in a new tab)
- AllSci News · 2026-10-09 · Roche's Tecentriq wins 12th FDA indication, for stage III colon cancer (opens the source in a new tab)
- Medical Daily · 2026-10-09 · RAPTURE Preworkout Recalled Nationwide Five Months After FDA Warned It Contained DMAA, a Stimulant Linked to Heart Problems (opens the source in a new tab)
- Chemical & Engineering News · 2026-10-09 · Policy Watch: FDA moves toward clinical trials of the psychedelic ibogaine (opens the source in a new tab)
What is claimed about it
- Corroborated: Reported by three or more sources that did not copy each other.
- Reported by two: Reported by two sources that did not copy each other.
- Single source: Reported by one source so far.
- FDA approves atezolizumab in combination with chemotherapy for Stage III mismatch repair deficient colon cancer Corroborated · first reported 8 Oct 2026
- FDA Advisory No.2026-1507 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product “UNBRANDED ARM SLING Single source · first reported 7 Oct 2026
- FDA Seeks Public Input On Psychedelic Research Involving Ibogaine Reported by two · first reported 6 Oct 2026
- 2026 fda approved weight loss drug retatrutide approval status Reported by two · first reported 4 Oct 2026